RTS names Richard Carpenter mid-Atlantic sales manager

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager.

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager. Carpenter has extensive experience in the scientific instrument market and expands the US field-based sales team.

Prior to joining RTS, Carpenter worked for LabCyte and Tecan, where he became an expert in robotics and liquid handling systems.




You may also like

Manufacturing

Software upgrade for RTS Tube Auditor

Improves screening quality, reduces costs and saves time
Manufacturing

Thermo Fisher expands collaboration Multiply Labs for automated cell therapy manufacturing

The strategic collaboration will aim to integrate robot automation with the Gibco CTS DynaCellect Magnetic Separation System for a more efficient manufacturing process
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Human-machine symbiosis: why Industry 5.0 is the future of pharmaceutical manufacturing

Industry 5.0 is reshaping pharmaceutical manufacturing by fostering human-machine collaboration, addressing workforce shortages and making advanced automation accessible to all through innovative models such as robot rental
Manufacturing

The future of powder dispersion

ystral presented high-shear vacuum expansion technology at POWTECH
Manufacturing

Symbiosis expands sterile manufacturing capacity with fill/finish line qualification

Symbiosis has maintained a track record of successful GMP inspections with both the FDA and MHRA since it was founded
Manufacturing

Indena accelerates CDMO innovation with advanced facilities and cutting-edge tech

In 2025, Indena completed several facility upgrades that have increased the quality, versatility and reliability of the CDMO services it offers for partners
Regulatory

Trump warning: drugmakers must expand US manufacturing or face tariffs

The president announced a new 100% tariff on branded medicines unless manufacturers are already building US plants
Subscribe now